all report title image

SPINAL MUSCULAR ATROPHY MARKET ANALYSIS

Spinal Muscular Atrophy Market, by Type (Type I, Type II, Type III, and Type IV), by Treatment (Gene Therapy and Disease-modifying drugs), by Age Group (Infant and Adult), by Route of Administration (Oral and Injectables), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031

  • Published In : Mar 2024
  • Code : CMI1920
  • Pages :156
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Spinal Muscular Atrophy MarketSize and Trends

Global spinal muscular atrophy market is estimated to be valued at USD 2,013.5 Mn in 2024 and is expected to exhibit a CAGR of 13.3% during the forecast period (2024-2031). 

Figure 1. Global Spinal Muscular Atrophy Market Value (US$ Mn), by Region, 2024

Spinal Muscular Atrophy Market Regional Insights, 2024

Increasing prevalence of spinal muscular atrophy is expected to drive growth of spinal muscular atrophy market

The increasing prevalence of spinal muscular atrophy (SMA) is expected to drive the market growth over the forecast period. For instance, according to the Spinal Muscular Atrophy Foundation, a voluntary organization whose mission is to accelerate the development of a treatment for spinal muscular atrophy, SMA is believed to affect around 10,000 to 25,000 children and adults in the U.S., and therefore it is one of the most common rare diseases.

Market Trends & Insights:

Increasing prevalence of spinal muscular atrophy is expected to drive growth of spinal muscular atrophy market

The increasing prevalence of spinal muscular atrophy (SMA) is expected to drive the market growth over the forecast period. For instance, according to the Spinal Muscular Atrophy Foundation, a voluntary organization whose mission is to accelerate the development of a treatment for spinal muscular atrophy, SMA is believed to affect around 10,000 to 25,000 children and adults in the U.S., and therefore it is one of the most common rare diseases.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.